Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidumUlrike Grienke, Judith M. Rollinger, Judit Mihaly‐Bison et al.|Bioorganic & Medicinal Chemistry|2011Cited by 72
Identification of plumericin as a potent new inhibitor of the <scp>NF</scp>‐<scp>κB</scp> pathway with anti‐inflammatory activity <i>in vitro</i> and <i>in vivo</i>Nanang Fakhrudin, Verena M. Dirsch, Muris Cabaravdic et al.|British Journal of Pharmacology|2013Cited by 68
Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validationDaniela Schuster, Gerhard Wolber, Patrick Markt et al.|Bioorganic & Medicinal Chemistry|2011Cited by 50
Plant extracts in cell-based anti-inflammatory assays—Pitfalls and considerations related to removal of activity masking bulk componentsPaolo Picker, Brigitte Kopp, Sylvia Vogl et al.|Phytochemistry Letters|2014Cited by 11
Discovery of Plumericin as a novel potent NF-κB inhibitor from Himatanthus sucuubaNanang Fakhrudin, Verena M. Dirsch, Birgit Waltenberger et al.|Planta Medica|2013Cited by 1